Abstract
Vaginal administration of the nitric oxide donor isosorbide mononitrate can induce effective ripening of the human cervix. We investigated whether this drug is associated with fewer side-effects than prostaglandins when used to ripen the cervix before first-trimester surgical termination of pregnancy, and assessed whether the extent of cervical ripening it induces is clinically sufficient.
Original language | English |
---|---|
Pages (from-to) | 1093-6 |
Number of pages | 4 |
Journal | The Lancet |
Volume | 352 |
Issue number | 9134 |
DOIs | |
Publication status | Published - 1998 |